125
Participants
Start Date
June 5, 2023
Primary Completion Date
December 1, 2027
Study Completion Date
March 1, 2028
safusidenib
safusidenib administered continuously as dosed single agent orally on Days 1 to 28 of a 28-day cycle. Subjects may continue treatment with agent safusidenib until disease progression or development of other unacceptable toxicity.
Placebo
Placebo administered continuously as dosed single agent orally on Days 1 to 28 of a 28-day cycle. Subjects may continue treatment with placebo until disease progression or another reason for discontinuation occurs.
NOT_YET_RECRUITING
New York University Langone Health, New York
RECRUITING
Columbia University Medical Center, New York
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
UVA Health, Emily Couric Clinical Cancer Cente, Charlottesville
RECRUITING
Duke Cancer Institute, Durham
NOT_YET_RECRUITING
Mayo Clinic - Florida, Jacksonville
NOT_YET_RECRUITING
University of Florida Health, Gainesville
NOT_YET_RECRUITING
Orlando Health Cancer Institute, Orlando
NOT_YET_RECRUITING
University of Miami Health, Miami
RECRUITING
University of Alabama, Birmingham
RECRUITING
Cleveland Clinic, Cleveland
NOT_YET_RECRUITING
Henry Ford Hospital, Detroit
NOT_YET_RECRUITING
University of Wisconsin Health, Madison
RECRUITING
Mayo Clinic - Rochester, Rochester
NOT_YET_RECRUITING
Washington University, St Louis
NOT_YET_RECRUITING
University of Kansas Medical Center, Kansas City
NOT_YET_RECRUITING
University of Texas Southwestern Medical Center, Dallas
NOT_YET_RECRUITING
MD Anderson Cancer Center, Houston
NOT_YET_RECRUITING
University of Colorado Health Cancer Care, Aurora
RECRUITING
Huntsman Cancer Insititute, University of Utah, Salt Lake City
RECRUITING
Mayo Clinic - Arizona, Phoenix
RECRUITING
St. Joseph's Hospital and Medical Center, Phoenix
NOT_YET_RECRUITING
University of California, Los Angeles, Los Angeles
RECRUITING
Hoag Memorial Hospital Presbyterian, Newport Beach
NOT_YET_RECRUITING
University of California, San Francisco
NOT_YET_RECRUITING
Stanford University, Palo Alto
NOT_YET_RECRUITING
Fred Hutch Cancer Center, Seattle
RECRUITING
Yale University, New Haven
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
Rutgers Cancer Institute, New Brunswick
Lead Sponsor
Collaborators (1)
AnHeart Therapeutics Inc.
INDUSTRY
Nuvation Bio Inc.
INDUSTRY